Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Harvard Business School
Cantor Fitzgerald
Merck
Accenture
Argus Health
Covington
AstraZeneca
Johnson and Johnson
Teva

Generated: August 20, 2017

DrugPatentWatch Database Preview

ARIPIPRAZOLE Drug Profile

« Back to Dashboard

Which patents cover Aripiprazole, and what generic Aripiprazole alternatives are available?

Aripiprazole is a drug marketed by Alembic Pharms Ltd, Amneal Pharms, Teva Pharms Usa, Aurobindo Pharma Ltd, Macleods Pharms Ltd, Torrent Pharms Ltd, Accord Hlthcare, Hetero Labs Ltd V, Silarx Pharms Inc, Ajanta Pharma Ltd, Santos Biotech, Apotex Inc, Orchid Hlthcare, and Sciegen Pharms Inc. and is included in nineteen NDAs.

The generic ingredient in ARIPIPRAZOLE is aripiprazole. There are forty-four drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. There are four tentative approvals for this compound. Additional details are available on the aripiprazole profile page.

Summary for Tradename: ARIPIPRAZOLE

Patents:0
Applicants:14
NDAs:19
Suppliers / Packagers: see list29
Bulk Api Vendors: see list94
Clinical Trials: see list315
Patent Applications: see list3,269
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:ARIPIPRAZOLE at DailyMed

Pharmacology for Tradename: ARIPIPRAZOLE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orchid Hlthcare
ARIPIPRAZOLE
aripiprazole
TABLET;ORAL202683-002May 23, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Accord Hlthcare
ARIPIPRAZOLE
aripiprazole
TABLET;ORAL206251-002Dec 7, 2016ABRXNoNo► Subscribe► Subscribe► Subscribe
Torrent Pharms Ltd
ARIPIPRAZOLE
aripiprazole
TABLET;ORAL201519-005Apr 28, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Hetero Labs Ltd V
ARIPIPRAZOLE
aripiprazole
TABLET;ORAL205064-004Apr 28, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
Santos Biotech
ARIPIPRAZOLE
aripiprazole
TABLET;ORAL091279-002Jan 9, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Medtronic
Dow
Teva
Queensland Health
Daiichi Sankyo
Mallinckrodt
Baxter
Colorcon
US Department of Justice
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot